# Collegium Pharmaceutical, Inc. (COLL)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/COLL/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 193.52M | $ 14.50M | $ 56.84M | $ 808.06M | $ 312.42M |
| 2025 | $ 799.23M | $ 64.37M | $ 335.42M | $ 940.56M | $ 301.68M |
| 2024 | $ 663.70M | $ 72.72M | $ 213.71M | $ 859.30M | $ 228.84M |
| 2023 | $ 612.82M | $ 52.07M | $ 296.57M | $ 674.28M | $ 195.43M |
| 2022 | $ 518.26M | $ -27.93M | $ 136.97M | $ 709.18M | $ 194.84M |
| 2021 | $ 329.10M | $ 85.01M | $ 120.78M | $ 258.75M | $ 202.93M |
| 2020 | $ 394.94M | $ 34.08M | $ 112.61M | $ 266.58M | $ 186.03M |
| 2019 | $ 382.97M | $ -29.33M | $ 27.55M | $ 21.59M | $ 87.43M |
| 2018 | $ 370.34M | $ -51.68M | $ 191.55M | $ 11.50M | $ 91.59M |
| 2017 | $ 38.36M | $ -100.85M | $ -91.62M | $ 1.48M | $ 104.08M |
| 2016 | $ 2.35M | $ -129.57M | $ -103.92M | $ 4.15M | $ 134.91M |
| 2015 | $ 0 | $ -38.27M | $ -30.79M | $ 6.81M | $ 85.07M |
| 2014 | $ 0 | $ -25.31M | $ -25.37M | $ 13.01M | $ -12.24M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 2.59 |
| Liabilities / Eq | 4.29 |
| Current Ratio | 1.71 |

## Debt coverage

| Indicator | Value |
| --- | --- |
| Gross Debt / Earnings | 1,639.52 |
| Gross Debt / FCF | 6.16 |

## Other views

- [Metrics](https://sponda.capital/en/COLL.md)
- [Charts](https://sponda.capital/en/COLL/charts.md)
- [Compare](https://sponda.capital/en/COLL/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.